Area of research
Molecular Biology · Hematology
Research interest
Research focused on Cancer research and Peroxiredoxin, with related work in Endocrinology, RhoC, Cell growth. Notable publications include 'Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells', 'BCAA–BCKA axis regulates WAT browning through acetylation of PRDM16', and 'Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression'.
Multi-omic spatial effects on high-resolution AI-derived retinal thickness
Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression
BCAA–BCKA axis regulates WAT browning through acetylation of PRDM16
ANP32B-mediated repression of p53 contributes to maintenance of normal and CML stem cells
Overexpression of Fbxo6 inactivates spindle checkpoint by interacting with Mad2 and BubR1
Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation
CDDO-Me reveals USP7 as a novel target in ovarian cancer cells
Natural products against hematological malignancies and identification of their targets
Preventive and Therapeutic Effects of Adenanthin on Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling
Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells
Autophagy inhibition enhances isobavachalcone-induced cell death in multiple myeloma cells